TransMedics Group, Inc. provided revenue guidance for the full-year 2024. For the period, the company expects total revenue for full-year 2024 to be in the range of $360 million to $370 million, which represents 49% to 53% growth compared to the company's prior year revenue.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
94.88 USD | +3.04% | +9.57% | +20.09% |
Apr. 18 | Transmedics Group Insider Sold Shares Worth $380,480, According to a Recent SEC Filing | MT |
Apr. 05 | Transmedics Group Insider Sold Shares Worth $802,084, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.09% | 3.02B | |
+8.67% | 219B | |
+7.37% | 183B | |
+11.38% | 133B | |
+25.32% | 108B | |
+0.72% | 63.06B | |
+12.49% | 52.02B | |
-0.62% | 48.2B | |
-0.19% | 40.37B | |
+13.30% | 39.35B |
- Stock Market
- Equities
- TMDX Stock
- News TransMedics Group, Inc.
- Transmedics Group, Inc. Provides Revenue Guidance for the Full-Year 2024